ArticleFrontiers in neurology2021

Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar.

Farzad Fatehi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.